Content area

Details

Title
Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours
Author
Oosting, Sjoukje F 1 ; Astrid A M van der Veldt 2 ; Fehrmann, Rudolf S N 1 ; GeurtsvanKessel, Corine H 3 ; van Binnendijk, Rob S 4 ; Dingemans, Anne-Marie C 5 ; Smit, Egbert F 6 ; T Jeroen N Hiltermann 7 ; den Hartog, Gerco 4 ; Jalving, Mathilda 1 ; Westphal, Tatjana T 8 ; Bhattacharya, Arkajyoti 1 ; de Wilt, Faye 3 ; Boerma, Annemarie 9 ; Lisanne van Zijl 10 ; Rimmelzwaan, Guus F 11 ; Kvistborg, Pia 12 ; Cecile A C M van Els 13 ; Rots, Nynke Y 4 ; Debbie van Baarle 9 ; John B A G Haanen 10 ; Elisabeth G E de Vries 1 

 Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands 
 Department of Medical Oncology, Erasmus Medical Centre, 3015 GD Rotterdam, Netherlands; Department of Radiology and Nuclear Medicine, Erasmus Medical Centre, 3015 GD Rotterdam, Netherlands 
 Department of Viroscience, Erasmus Medical Centre, 3015 GD Rotterdam, Netherlands 
 Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands 
 Department of Respiratory Medicine, Erasmus Medical Centre, 3015 GD Rotterdam, Netherlands 
 Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands 
 Department of Pulmonary Diseases, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands 
 Netherlands Comprehensive Cancer Organization, Utrecht, Netherlands 
 Department of Medical Microbiology and Infection Prevention, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands 
10  Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands 
11  Research Centre for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Hannover, Germany 
12  Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands 
13  Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands; Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands 
Pages
833-835
Section
Comment
Publication year
2022
Publication date
Jul 2022
Publisher
Elsevier Limited
ISSN
14702045
e-ISSN
14745488
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2681392300
Copyright
©2022. Elsevier Ltd